Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study.

Mbuba CK, Ngugi AK, Fegan G, Ibinda F, Muchohi SN, Nyundo C, Odhiambo R, Edwards T, Odermatt P, Carter JA, Newton CR.

Lancet Neurol. 2012 Aug;11(8):688-96. doi: 10.1016/S1474-4422(12)70155-2. Epub 2012 Jul 6.

2.

Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs.

Chapman SC, Horne R, Eade R, Balestrini S, Rush J, Sisodiya SM.

Epilepsia. 2015 Sep;56(9):1398-407. doi: 10.1111/epi.13097. Epub 2015 Jul 27.

3.

Evaluation of Kilifi epilepsy education programme: a randomized controlled trial.

Ibinda F, Mbuba CK, Kariuki SM, Chengo E, Ngugi AK, Odhiambo R, Lowe B, Fegan G, Carter JA, Newton CR.

Epilepsia. 2014 Feb;55(2):344-52. doi: 10.1111/epi.12498. Epub 2014 Jan 21.

4.

Epilepsy-associated levels of perceived stigma, their associations with treatment, and related factors: A cross-sectional study in urban and rural areas in Ecuador.

Luna J, Nizard M, Becker D, Gerard D, Cruz A, Ratsimbazafy V, Dumas M, Cruz M, Preux PM.

Epilepsy Behav. 2017 Mar;68:71-77. doi: 10.1016/j.yebeh.2016.12.026. Epub 2017 Jan 19.

PMID:
28109993
5.

The reasons for the epilepsy treatment gap in Kilifi, Kenya: using formative research to identify interventions to improve adherence to antiepileptic drugs.

Carter JA, Molyneux CS, Mbuba CK, Jenkins J, Newton CR, Hartley SD.

Epilepsy Behav. 2012 Dec;25(4):614-21. doi: 10.1016/j.yebeh.2012.07.009. Epub 2012 Nov 15.

6.

Attitudes and practices of families and health care personnel toward children with epilepsy in Kilifi, Kenya.

El Sharkawy G, Newton C, Hartley S.

Epilepsy Behav. 2006 Feb;8(1):201-12. Epub 2005 Nov 7.

PMID:
16275111
7.

Patients' perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care.

Chapman SC, Horne R, Chater A, Hukins D, Smithson WH.

Epilepsy Behav. 2014 Feb;31:312-20. doi: 10.1016/j.yebeh.2013.10.016. Epub 2013 Nov 27.

8.

Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross-sectional multisite study.

Ibinda F, Odermatt P, Kariuki SM, Kakooza-Mwesige A, Wagner RG, Owusu-Agyei S, Masanja H, Ngugi AK, Mbuba CK, Doku VCK, Neville BG, Sander JW, Newton CRJC; SEEDS writing group.

Epilepsia Open. 2017 Mar 30;2(2):226-235. doi: 10.1002/epi4.12052. eCollection 2017 Jun.

9.

Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors.

Edwards T, Scott AG, Munyoki G, Odera VM, Chengo E, Bauni E, Kwasa T, Sander LW, Neville BG, Newton CR.

Lancet Neurol. 2008 Jan;7(1):50-6.

10.

Adherence and complementary and alternative medicine use among Honduran people with epilepsy.

Durón RM, Medina MT, Nicolás O, Varela FE, Ramírez F, Battle SJ, Thompson A, Rodríguez LC, Oseguera C, Aguilar-Estrada RL, Pietsch-Escueta S, Collins JS, Holden KR.

Epilepsy Behav. 2009 Apr;14(4):645-50. doi: 10.1016/j.yebeh.2009.01.022. Epub 2009 Feb 4.

PMID:
19435580
11.

Association between sociodemographic status and antiepileptic drug prescriptions in children with epilepsy.

Mattsson P, Tomson T, Edebol Eeg-Olofsson K, Brännström L, Ringbäck Weitoft G.

Epilepsia. 2012 Dec;53(12):2149-55. doi: 10.1111/j.1528-1167.2012.03717.x. Epub 2012 Oct 12.

12.

Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients.

Mattsson P, Tomson T, Eriksson O, Brännström L, Weitoft GR.

Neurology. 2010 Jan 26;74(4):295-301. doi: 10.1212/WNL.0b013e3181cbcd5c.

PMID:
20101034
13.

Burden of epilepsy in rural Kenya measured in disability-adjusted life years.

Ibinda F, Wagner RG, Bertram MY, Ngugi AK, Bauni E, Vos T, Sander JW, Newton CR.

Epilepsia. 2014 Oct;55(10):1626-33. doi: 10.1111/epi.12741. Epub 2014 Jul 31.

14.

Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy.

Getnet A, Woldeyohannes SM, Bekana L, Mekonen T, Fekadu W, Menberu M, Yimer S, Assaye A, Belete A, Belete H.

Behav Neurol. 2016;2016:3189108. doi: 10.1155/2016/3189108. Epub 2016 Dec 8.

15.

Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.

Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG, Kakooza-Mwesige A, Ae-Ngibise K, Owusu-Agyei S, Masanja H, Kamuyu G, Odhiambo R, Chengo E, Sander JW, Newton CR; SEEDS group.

Lancet Neurol. 2013 Mar;12(3):253-63. doi: 10.1016/S1474-4422(13)70003-6. Epub 2013 Jan 31.

16.

Pharmacists' knowledge of issues in pharmacotherapy of epilepsy using antiepileptic drugs: A cross-sectional study in Palestinian pharmacy practice.

Shawahna R, Atrash A, Jebril A, Khalaf A, Shaheen E, Tahboosh H.

Epilepsy Behav. 2017 Feb;67:39-44. doi: 10.1016/j.yebeh.2016.11.027. Epub 2017 Jan 12.

PMID:
28088050
17.

Suicidality in people taking antiepileptic drugs: What is the evidence?

Bell GS, Mula M, Sander JW.

CNS Drugs. 2009;23(4):281-92.

PMID:
19374458
18.

Recent changes in attitudes of US adults toward people with epilepsy - Results from the 2005 SummerStyles and 2013 FallStyles surveys.

Cui W, Kobau R, Zack MM, Buelow JM, Austin JK.

Epilepsy Behav. 2015 Nov;52(Pt A):108-18. doi: 10.1016/j.yebeh.2015.08.040. Epub 2015 Sep 25.

19.

An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study.

Gurumurthy R, Chanda K, Sarma G.

Singapore Med J. 2017 Feb;58(2):98-102. doi: 10.11622/smedj.2016022. Epub 2016 Jan 25.

20.

Antiepileptic drugs for seizure control in people with neurocysticercosis.

Sharma M, Singh T, Mathew A.

Cochrane Database Syst Rev. 2015 Oct 12;(10):CD009027. doi: 10.1002/14651858.CD009027.pub2. Review.

PMID:
26455722

Supplemental Content

Support Center